The impact of recombinant DNA technology on genetic screening.
D000025:Abortion, Eugenic; D033421:Beginning of Human Life; D003068:Coercion; D004274:DNA, Recombinant; D006233:Persons with Disabilities; D004467:Economics; D004989:Ethics; D005053:Eugenics; D005333:Fetus; D005817:Genetic Counseling; D030342:Genetic Diseases, Inborn; D005820:Genetic Testing; D015316:Genetic Therapy; D006579:Heterozygote; D006801:Humans; D007206:Individuality; D016365:Liability, Legal; D019369:Life; D037141:Mandatory Programs; D008403:Mass Screening; D028723:Personhood; D011296:Prenatal Diagnosis; D011640:Public Policy; D011788:Quality of Life; D012306:Risk; D018570:Risk Assessment; D012922:Social Change; D013240:Stereotyping; D013315:Stress, Psychological; D014481:United States; D026712:Value of Life; D035141:Voluntary Programs; D015974:Wrongful Life
Biomedical and Behavioral Research; Genetics and Reproduction